Clinical Trial Update: What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression? [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the antidepressant mechanism of action of quetiapine in bipolar depression was withdrawn, with no trial results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: University of British Columbia | Conditions: Bipolar Depression | Phase 3 | Status: WITHDRAWN